Share Price and Basic Stock Data
Last Updated: February 10, 2026, 9:21 pm
| PEG Ratio | -4.24 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Quick Heal Technologies Ltd operates within the IT Consulting and Software sector, focusing primarily on cybersecurity solutions. The company’s stock price stood at ₹180, with a market capitalization of ₹975 Cr. Revenue trends indicate a fluctuating performance over the past quarters. Sales recorded in December 2022 were ₹66.80 Cr, declining to ₹49.28 Cr in March 2023, before making a recovery to ₹78.36 Cr by September 2023. However, the latest figures indicate sales of ₹81.92 Cr in December 2023. Annually, the sales for FY 2023 totaled ₹278 Cr, a decline from ₹342 Cr in FY 2022. The trailing twelve months (TTM) revenue is reported at ₹276 Cr, reflecting ongoing challenges in sustaining consistent growth. This revenue volatility could be attributed to competitive pressures and changing market dynamics in the cybersecurity landscape.
Profitability and Efficiency Metrics
Profitability remains a significant concern for Quick Heal Technologies, as evidenced by its reported net profit of -₹1 Cr. The operating profit margin (OPM) stood at a mere 0.63%, highlighting the company’s struggle to convert sales into profit effectively. Analyzing quarterly performance, OPM fluctuated dramatically, with a notable recovery to 14.18% in December 2023, following a low of -32.81% in March 2023. The company’s return on equity (ROE) was recorded at 0.63%, while the return on capital employed (ROCE) was substantially lower at 0.24%. These figures are considerably below typical sector benchmarks, indicating potential inefficiencies in asset utilization and capital management. The interest coverage ratio (ICR) was exceptionally high at 64.45x, suggesting that the company can comfortably meet its interest obligations, although it has no borrowings, reflecting a conservative capital structure.
Balance Sheet Strength and Financial Ratios
Quick Heal’s balance sheet reflects a solid financial position, with total reserves amounting to ₹392 Cr and no borrowings, indicating a debt-free status. The current ratio stood at a robust 4.72, which is significantly higher than the typical sector range, suggesting strong liquidity and an ability to cover short-term liabilities. However, the price-to-book value (P/BV) ratio of 3.51x signifies a premium valuation compared to book value per share of ₹81.75. The company’s cash conversion cycle (CCC) increased to 218 days, which is concerning as it indicates inefficiencies in working capital management. The efficiency metrics show a decline in return on assets (ROA) to 0.95%, reflecting challenges in generating returns from its asset base. Overall, while the company maintains a strong balance sheet, the efficiency ratios raise flags regarding operational effectiveness.
Shareholding Pattern and Investor Confidence
As of September 2025, Quick Heal Technologies had a diverse shareholding structure, with promoters holding 71.63% of the company. Foreign institutional investors (FIIs) accounted for 0.50%, while domestic institutional investors (DIIs) held 2.33%. The public shareholding stood at 25.53%, indicating reasonable liquidity in the stock. Over recent quarters, promoter holdings have gradually decreased from 73.08% in December 2022, which may suggest a potential shift in investor confidence or a strategic realignment. The number of shareholders increased to 55,910, reflecting a growing interest in the company’s equity despite its recent financial challenges. The high promoter stake suggests a strong commitment to the company’s long-term vision, but the declining trend in their holdings may warrant close observation as it could influence market sentiment.
Outlook, Risks, and Final Insight
Looking forward, Quick Heal Technologies faces both opportunities and risks. The ongoing demand for cybersecurity solutions presents a significant growth avenue, particularly as businesses increasingly prioritize digital security. However, the company must address its profitability challenges, as indicated by the negative net profit and low operating margins. Key risks include heightened competition in the cybersecurity sector and potential market fluctuations that could impact revenue generation. Additionally, the rising cash conversion cycle suggests that the company needs to optimize its working capital management. If Quick Heal can effectively leverage its strong balance sheet and address operational inefficiencies, it may strengthen its market position. Conversely, failure to improve profitability could hinder its growth trajectory, necessitating strategic adjustments to adapt to the evolving market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 42.5 Cr. | 13.4 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 130 Cr. | 120 | 194/99.8 | 19.8 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 46.0 Cr. | 359 | 446/140 | 28.8 | 26.7 | 0.28 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 12.0 Cr. | 2.23 | 2.23/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 19,247.75 Cr | 521.10 | 73.53 | 123.52 | 0.62% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.80 | 49.28 | 51.44 | 78.36 | 81.92 | 80.03 | 70.29 | 73.49 | 70.61 | 65.14 | 57.23 | 83.52 | 71.54 |
| Expenses | 78.17 | 65.45 | 66.52 | 67.39 | 70.30 | 69.99 | 67.70 | 70.42 | 74.38 | 73.62 | 66.96 | 74.29 | 71.09 |
| Operating Profit | -11.37 | -16.17 | -15.08 | 10.97 | 11.62 | 10.04 | 2.59 | 3.07 | -3.77 | -8.48 | -9.73 | 9.23 | 0.45 |
| OPM % | -17.02% | -32.81% | -29.32% | 14.00% | 14.18% | 12.55% | 3.68% | 4.18% | -5.34% | -13.02% | -17.00% | 11.05% | 0.63% |
| Other Income | 3.47 | 10.06 | 4.73 | 5.69 | 4.15 | 6.82 | 5.06 | 5.20 | 4.91 | 5.60 | 5.75 | 4.38 | 8.95 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
| Depreciation | 4.17 | 3.73 | 2.93 | 3.25 | 3.24 | 3.18 | 2.79 | 3.15 | 3.39 | 3.63 | 2.96 | 3.28 | 3.59 |
| Profit before tax | -12.07 | -9.84 | -13.28 | 13.41 | 12.53 | 13.55 | 4.81 | 5.07 | -2.31 | -6.57 | -7.00 | 10.28 | 5.75 |
| Tax % | -23.03% | -32.52% | -3.92% | 3.80% | 19.71% | -3.62% | 16.22% | 18.15% | -104.76% | -50.53% | -21.29% | 23.05% | -14.96% |
| Net Profit | -9.29 | -6.64 | -12.76 | 12.90 | 10.06 | 14.04 | 4.03 | 4.15 | 0.11 | -3.25 | -5.51 | 7.91 | 6.61 |
| EPS in Rs | -1.75 | -1.25 | -2.40 | 2.43 | 1.89 | 2.62 | 0.75 | 0.77 | 0.02 | -0.60 | -1.02 | 1.46 | 1.22 |
Last Updated: February 4, 2026, 12:16 pm
Below is a detailed analysis of the quarterly data for Quick Heal Technologies Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 71.54 Cr.. The value appears to be declining and may need further review. It has decreased from 83.52 Cr. (Sep 2025) to 71.54 Cr., marking a decrease of 11.98 Cr..
- For Expenses, as of Dec 2025, the value is 71.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 74.29 Cr. (Sep 2025) to 71.09 Cr., marking a decrease of 3.20 Cr..
- For Operating Profit, as of Dec 2025, the value is 0.45 Cr.. The value appears to be declining and may need further review. It has decreased from 9.23 Cr. (Sep 2025) to 0.45 Cr., marking a decrease of 8.78 Cr..
- For OPM %, as of Dec 2025, the value is 0.63%. The value appears to be declining and may need further review. It has decreased from 11.05% (Sep 2025) to 0.63%, marking a decrease of 10.42%.
- For Other Income, as of Dec 2025, the value is 8.95 Cr.. The value appears strong and on an upward trend. It has increased from 4.38 Cr. (Sep 2025) to 8.95 Cr., marking an increase of 4.57 Cr..
- For Interest, as of Dec 2025, the value is 0.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Sep 2025) to 0.06 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Dec 2025, the value is 3.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.28 Cr. (Sep 2025) to 3.59 Cr., marking an increase of 0.31 Cr..
- For Profit before tax, as of Dec 2025, the value is 5.75 Cr.. The value appears to be declining and may need further review. It has decreased from 10.28 Cr. (Sep 2025) to 5.75 Cr., marking a decrease of 4.53 Cr..
- For Tax %, as of Dec 2025, the value is -14.96%. The value appears to be improving (decreasing) as expected. It has decreased from 23.05% (Sep 2025) to -14.96%, marking a decrease of 38.01%.
- For Net Profit, as of Dec 2025, the value is 6.61 Cr.. The value appears to be declining and may need further review. It has decreased from 7.91 Cr. (Sep 2025) to 6.61 Cr., marking a decrease of 1.30 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.22. The value appears to be declining and may need further review. It has decreased from 1.46 (Sep 2025) to 1.22, marking a decrease of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 243 | 286 | 302 | 300 | 318 | 315 | 286 | 333 | 342 | 278 | 292 | 280 | 276 |
| Expenses | 157 | 194 | 200 | 210 | 198 | 187 | 195 | 192 | 235 | 276 | 274 | 286 | 289 |
| Operating Profit | 85 | 92 | 102 | 90 | 120 | 128 | 92 | 141 | 107 | 2 | 18 | -7 | -13 |
| OPM % | 35% | 32% | 34% | 30% | 38% | 41% | 32% | 42% | 31% | 1% | 6% | -2% | -5% |
| Other Income | 11 | 8 | 10 | 25 | 30 | 33 | 31 | 24 | 19 | 22 | 21 | 21 | 21 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 20 | 24 | 31 | 27 | 24 | 22 | 19 | 17 | 16 | 13 | 13 | 13 |
| Profit before tax | 86 | 80 | 88 | 84 | 123 | 137 | 101 | 146 | 109 | 8 | 26 | 1 | -6 |
| Tax % | 32% | 33% | 34% | 37% | 33% | 33% | 27% | 27% | 23% | 20% | 8% | -404% | |
| Net Profit | 58 | 54 | 58 | 53 | 83 | 92 | 74 | 107 | 83 | 6 | 24 | 5 | -1 |
| EPS in Rs | 9.56 | 8.81 | 8.27 | 7.59 | 11.79 | 13.01 | 11.59 | 16.66 | 14.34 | 1.21 | 4.53 | 0.93 | -0.14 |
| Dividend Payout % | 78% | 85% | 30% | 33% | 25% | 15% | 35% | 24% | 31% | 207% | 66% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -6.90% | 7.41% | -8.62% | 56.60% | 10.84% | -19.57% | 44.59% | -22.43% | -92.77% | 300.00% | -79.17% |
| Change in YoY Net Profit Growth (%) | 0.00% | 14.30% | -16.03% | 65.22% | -45.76% | -30.41% | 64.16% | -67.02% | -70.34% | 392.77% | -379.17% |
Quick Heal Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | -14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -41% |
| 3 Years: | -60% |
| TTM: | -111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 11% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 8% |
| 3 Years: | 2% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 12:50 pm
Balance Sheet
Last Updated: January 7, 2026, 4:16 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 61 | 61 | 70 | 70 | 70 | 71 | 64 | 64 | 58 | 53 | 54 | 54 | 54 |
| Reserves | 271 | 270 | 559 | 592 | 653 | 719 | 580 | 687 | 570 | 367 | 383 | 387 | 392 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 47 | 97 | 88 | 72 | 57 | 63 | 52 | 75 | 88 | 74 | 76 | 83 | 99 |
| Total Liabilities | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
| Fixed Assets | 82 | 111 | 142 | 185 | 173 | 165 | 158 | 146 | 137 | 124 | 117 | 119 | 117 |
| CWIP | 55 | 74 | 55 | 14 | 14 | 11 | 3 | 2 | 0 | 0 | 3 | 0 | 9 |
| Investments | 131 | 130 | 115 | 182 | 306 | 390 | 310 | 416 | 318 | 198 | 190 | 179 | 185 |
| Other Assets | 111 | 113 | 405 | 353 | 287 | 288 | 225 | 263 | 261 | 171 | 203 | 226 | 234 |
| Total Assets | 380 | 428 | 717 | 734 | 781 | 853 | 697 | 827 | 716 | 493 | 513 | 525 | 545 |
Below is a detailed analysis of the balance sheet data for Quick Heal Technologies Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 54.00 Cr..
- For Reserves, as of Sep 2025, the value is 392.00 Cr.. The value appears strong and on an upward trend. It has increased from 387.00 Cr. (Mar 2025) to 392.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 99.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 83.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 16.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 117.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Mar 2025) to 117.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 9.00 Cr..
- For Investments, as of Sep 2025, the value is 185.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Mar 2025) to 185.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Sep 2025, the value is 234.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2025) to 234.00 Cr., marking an increase of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 545.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 20.00 Cr..
Notably, the Reserves (392.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 85.00 | 92.00 | 102.00 | 90.00 | 120.00 | 128.00 | 92.00 | 141.00 | 107.00 | 2.00 | 18.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 104 | 83 | 112 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Inventory Days | 181 | 144 | ||||||||||
| Days Payable | 864 | 1,103 | ||||||||||
| Cash Conversion Cycle | 104 | -600 | -847 | 118 | 118 | 145 | 144 | 165 | 184 | 161 | 165 | 218 |
| Working Capital Days | 52 | -23 | 29 | 49 | 70 | 92 | 94 | 98 | 102 | 83 | 88 | 354 |
| ROCE % | 27% | 24% | 18% | 14% | 18% | 18% | 14% | 21% | 15% | 0% | 6% | 0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Digital India Fund | 425,000 | 0.09 | 11.29 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.94 | 4.56 | 1.14 | 14.01 | 16.66 |
| Diluted EPS (Rs.) | 0.91 | 4.48 | 1.14 | 13.94 | 16.65 |
| Cash EPS (Rs.) | 3.33 | 6.88 | 4.22 | 17.34 | 19.70 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 81.75 | 81.67 | 79.09 | 108.19 | 117.04 |
| Revenue From Operations / Share (Rs.) | 51.76 | 54.52 | 52.40 | 58.94 | 51.87 |
| PBDIT / Share (Rs.) | 2.63 | 7.28 | 4.52 | 21.73 | 25.80 |
| PBIT / Share (Rs.) | 0.22 | 4.92 | 1.51 | 18.73 | 22.76 |
| PBT / Share (Rs.) | 0.18 | 4.90 | 1.51 | 18.73 | 22.76 |
| Net Profit / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| NP After MI And SOA / Share (Rs.) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 |
| PBDIT Margin (%) | 5.07 | 13.34 | 8.63 | 36.87 | 49.73 |
| PBIT Margin (%) | 0.43 | 9.02 | 2.88 | 31.78 | 43.87 |
| PBT Margin (%) | 0.35 | 8.98 | 2.88 | 31.78 | 43.87 |
| Net Profit Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| NP After MI And SOA Margin (%) | 1.80 | 8.30 | 2.30 | 24.33 | 32.12 |
| Return on Networth / Equity (%) | 1.14 | 5.54 | 1.52 | 13.25 | 14.23 |
| Return on Capital Employeed (%) | 0.27 | 5.99 | 1.90 | 17.25 | 19.41 |
| Return On Assets (%) | 0.95 | 4.72 | 1.29 | 11.62 | 12.94 |
| Asset Turnover Ratio (%) | 0.53 | 0.58 | 0.46 | 0.44 | 0.43 |
| Current Ratio (X) | 4.72 | 4.96 | 4.50 | 6.20 | 8.53 |
| Quick Ratio (X) | 4.69 | 4.93 | 4.43 | 6.15 | 8.49 |
| Inventory Turnover Ratio (X) | 111.37 | 0.11 | 0.23 | 0.24 | 0.21 |
| Dividend Payout Ratio (NP) (%) | 320.03 | 54.74 | 407.96 | 27.85 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 89.61 | 36.02 | 116.61 | 23.03 | 0.00 |
| Earning Retention Ratio (%) | -220.03 | 45.26 | -307.96 | 72.15 | 0.00 |
| Cash Earning Retention Ratio (%) | 10.39 | 63.98 | -16.61 | 76.97 | 0.00 |
| Interest Coverage Ratio (X) | 64.45 | 299.54 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 23.91 | 187.46 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1527.48 | 2480.96 | 695.04 | 966.92 | 1113.79 |
| EV / Net Operating Revenue (X) | 5.46 | 8.50 | 2.50 | 2.83 | 3.34 |
| EV / EBITDA (X) | 107.72 | 63.71 | 28.95 | 7.67 | 6.72 |
| MarketCap / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| Retention Ratios (%) | -220.03 | 45.25 | -307.96 | 72.14 | 0.00 |
| Price / BV (X) | 3.51 | 5.76 | 1.68 | 1.64 | 1.59 |
| Price / Net Operating Revenue (X) | 5.54 | 8.63 | 2.54 | 3.01 | 3.60 |
| EarningsYield | 0.00 | 0.01 | 0.01 | 0.08 | 0.08 |
After reviewing the key financial ratios for Quick Heal Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 5. It has decreased from 4.56 (Mar 24) to 0.94, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 5. It has decreased from 4.48 (Mar 24) to 0.91, marking a decrease of 3.57.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.33. This value is within the healthy range. It has decreased from 6.88 (Mar 24) to 3.33, marking a decrease of 3.55.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.75. It has increased from 81.67 (Mar 24) to 81.75, marking an increase of 0.08.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.76. It has decreased from 54.52 (Mar 24) to 51.76, marking a decrease of 2.76.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.63. This value is within the healthy range. It has decreased from 7.28 (Mar 24) to 2.63, marking a decrease of 4.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 4.92 (Mar 24) to 0.22, marking a decrease of 4.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.18. This value is within the healthy range. It has decreased from 4.90 (Mar 24) to 0.18, marking a decrease of 4.72.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 2. It has decreased from 4.53 (Mar 24) to 0.93, marking a decrease of 3.60.
- For PBDIT Margin (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 10. It has decreased from 13.34 (Mar 24) to 5.07, marking a decrease of 8.27.
- For PBIT Margin (%), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 10. It has decreased from 9.02 (Mar 24) to 0.43, marking a decrease of 8.59.
- For PBT Margin (%), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 10. It has decreased from 8.98 (Mar 24) to 0.35, marking a decrease of 8.63.
- For Net Profit Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 5. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 8. It has decreased from 8.30 (Mar 24) to 1.80, marking a decrease of 6.50.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 5.54 (Mar 24) to 1.14, marking a decrease of 4.40.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 10. It has decreased from 5.99 (Mar 24) to 0.27, marking a decrease of 5.72.
- For Return On Assets (%), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 5. It has decreased from 4.72 (Mar 24) to 0.95, marking a decrease of 3.77.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.53. It has decreased from 0.58 (Mar 24) to 0.53, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 4.72. This value exceeds the healthy maximum of 3. It has decreased from 4.96 (Mar 24) to 4.72, marking a decrease of 0.24.
- For Quick Ratio (X), as of Mar 25, the value is 4.69. This value exceeds the healthy maximum of 2. It has decreased from 4.93 (Mar 24) to 4.69, marking a decrease of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 111.37. This value exceeds the healthy maximum of 8. It has increased from 0.11 (Mar 24) to 111.37, marking an increase of 111.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 320.03. This value exceeds the healthy maximum of 50. It has increased from 54.74 (Mar 24) to 320.03, marking an increase of 265.29.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 89.61. This value exceeds the healthy maximum of 50. It has increased from 36.02 (Mar 24) to 89.61, marking an increase of 53.59.
- For Earning Retention Ratio (%), as of Mar 25, the value is -220.03. This value is below the healthy minimum of 40. It has decreased from 45.26 (Mar 24) to -220.03, marking a decrease of 265.29.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 10.39. This value is below the healthy minimum of 40. It has decreased from 63.98 (Mar 24) to 10.39, marking a decrease of 53.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 64.45. This value is within the healthy range. It has decreased from 299.54 (Mar 24) to 64.45, marking a decrease of 235.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.91. This value is within the healthy range. It has decreased from 187.46 (Mar 24) to 23.91, marking a decrease of 163.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,527.48. It has decreased from 2,480.96 (Mar 24) to 1,527.48, marking a decrease of 953.48.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has decreased from 8.50 (Mar 24) to 5.46, marking a decrease of 3.04.
- For EV / EBITDA (X), as of Mar 25, the value is 107.72. This value exceeds the healthy maximum of 15. It has increased from 63.71 (Mar 24) to 107.72, marking an increase of 44.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For Retention Ratios (%), as of Mar 25, the value is -220.03. This value is below the healthy minimum of 30. It has decreased from 45.25 (Mar 24) to -220.03, marking a decrease of 265.28.
- For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has decreased from 5.76 (Mar 24) to 3.51, marking a decrease of 2.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.54. This value exceeds the healthy maximum of 3. It has decreased from 8.63 (Mar 24) to 5.54, marking a decrease of 3.09.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Quick Heal Technologies Ltd:
- Net Profit Margin: 1.8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.27% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 179 (Industry average Stock P/E: 73.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Solitaire Business Hub, Pune Maharashtra 411014 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Kailash Sahebrao Katkar | Chairman & Managing Director |
| Dr. Sanjay Sahebrao Katkar | Joint Managing Director |
| Mr. Shailesh Lakhani | Non Executive Director |
| Mr. Amitabha Mukhopadhyay | Independent Director |
| Air M'shal (Retd.) Bhushan Nilkanth Gokhale | Independent Director |
| Ms. Apurva Pradeep Joshi | Independent Director |
| Mr. Richard Stiennon | Independent Director |
| Mr. Kamal Kumar Agarwal | Independent Director |
FAQ
What is the intrinsic value of Quick Heal Technologies Ltd?
Quick Heal Technologies Ltd's intrinsic value (as of 11 February 2026) is ₹43.84 which is 76.93% lower the current market price of ₹190.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,029 Cr. market cap, FY2025-2026 high/low of ₹455/173, reserves of ₹392 Cr, and liabilities of ₹545 Cr.
What is the Market Cap of Quick Heal Technologies Ltd?
The Market Cap of Quick Heal Technologies Ltd is 1,029 Cr..
What is the current Stock Price of Quick Heal Technologies Ltd as on 11 February 2026?
The current stock price of Quick Heal Technologies Ltd as on 11 February 2026 is ₹190.
What is the High / Low of Quick Heal Technologies Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Quick Heal Technologies Ltd stocks is ₹455/173.
What is the Stock P/E of Quick Heal Technologies Ltd?
The Stock P/E of Quick Heal Technologies Ltd is 179.
What is the Book Value of Quick Heal Technologies Ltd?
The Book Value of Quick Heal Technologies Ltd is 82.4.
What is the Dividend Yield of Quick Heal Technologies Ltd?
The Dividend Yield of Quick Heal Technologies Ltd is 0.00 %.
What is the ROCE of Quick Heal Technologies Ltd?
The ROCE of Quick Heal Technologies Ltd is 0.24 %.
What is the ROE of Quick Heal Technologies Ltd?
The ROE of Quick Heal Technologies Ltd is 0.63 %.
What is the Face Value of Quick Heal Technologies Ltd?
The Face Value of Quick Heal Technologies Ltd is 10.0.